(Q41503054)

1 October 2017

title

Evidence that lysolecithin is an important causal agent of atherosclerosis (English)

1 reference

1 October 2017

1 reference

Vidaver GA

1

1 reference

1 October 2017

Ting A

series ordinal

2

1 reference

1 October 2017

Lee JW

series ordinal

3

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 July 1985

1 reference

Journal of Theoretical Biology

1 October 2017

number of pages

15

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

1 October 2017

volume

115

1 reference

1 October 2017

issue

1

1 reference

1 October 2017

page(s)

27-41

1 reference

High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Relative rates of sterol synthesis in the liver and various extrahepatic tissues of normal and cholesterol-fed rabbits. Relationship to plasma lipoprotein and tissue cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Concerning the synthesis of lysolecithin and its ether analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Lecithin-cholesterol acyltransferase: inhibition by local anesthetics in plasma from man and experimental animals in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Inhibition of LCAT in plasma from man and experimental animals by chlorpromazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Cross-linking of SH-groups in the erythrocyte membrane enhances transbilayer reorientation of phospholipids. Evidence for a limited access of phospholipids to the reorientation sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Regulation of low density lipoprotein receptor activity by cultured human arterial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Tissue lipoprotein lipase activity and its action in lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

The role of lysolecithin in phospholipid metabolism of human umbilical and dog carotid arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Phospholipases in arterial tissue III. Phosphatide acyl-hydrolase, lysophosphatide acyl-hydrolase and sphingomyelin choline phosphohydrolase in rat and rabbit aorta in different age groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cellS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Plasma concentrations of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerotic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Plasma lecithin-cholesterol acyltransferase and erythrocyte lipids in liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Homocystinemia. Vascular injury and arterial thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

A survey of 246 suggested coronary risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Hyperlipidemia and coronary atherosclerosis: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Physical principles of membrane organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Plasma high density lipoproteins HDL2, HDL3 and postheparin plasma lipases in relation to parameters of physical fitness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Inhibition of the availability of platelet factor 3 by increased concentration of lecithin in platelets caused by gonadal steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Net esterification in vitro of plasma cholesterol in human primary hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

A method for the determination of the initial rate of reaction of lecithin: cholesterol acyltransferase in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Lipoproteins and plasma cholesterol esterification in normal and diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Oncogenes and inositol lipids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Lipoproteins and cholesterol esterification rate in men and women with hypercholesterolaemia of type IIa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Lipid-protein interactions in the plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Lipolytic enzymes and plasma lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Initial cholesterol esterif ication rate in hyperlipoproteinaemia: effects of triglyceride‐rich Iipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Preferential incorporation of fatty acids at the inside of human erythrocyte membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

The pathogenesis of atherosclerosis (first of two parts)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

The pathogenesis of atherosclerosis (second of two parts)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Hyperlipidemia and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Very low density lipoproteins: Surface-volume changes during metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Role of capillary endothelium in the clearance of chylomicrons. A model for lipid transport from blood by lateral diffusion in cell membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Serum cholesterol esterification in patients with coronary heart disease. Importance of initial rate of esterification expressed as a function of free cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Lecithin:cholesterol acyltransferase activity, plasma and lipoprotein lipids and obesity in men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Regulation of proliferation of normal and neoplastic rat liver cells by calcium and cyclic AMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Role of serum in inhibition of cultured lymphocytes by lysophosphatidylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Lecithin: Cholesterol acyl transfer rate in plasma and its relation to lipid and lipoprotein concentrations in primary hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Lecithin: cholesterol acyl transfer rate and high density lipoprotein level in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Cytolytic and membrane-perturbing properties of lysophosphatidylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

The roles of calcium and cyclic AMP in cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Lecithin : cholesterol acyl transfer (LACT) and fatty acid composition of lecithin and cholesterol esters in young male myocardial infarction survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

The effect of exercise on plasma high density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Self-adaptive modification of red-cell membrane lipids in lecithin: cholesterol acyltransferase deficiency. Lipid analysis and spin labeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

Investigation of relationship between lecithin:cholesterol acyltransferase activity and coronary atheroma, diagnosed by selective coronary angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Lysolecithin binding to human and squirrel monkey plasma and tissue components

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2885%2980005-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-5193(85)80005-9

1 reference

1 October 2017

1 reference